IL18 and Alzheimer disease: In in vitro LPS+Aβ42-stimulated PBMC, the production of IL-18, IL-1β and caspase-1 (p20 subunit) was significantly increased in AD patients compared to HC (p < 0.05) (Figure 2A–C).